In the last few days, Evotec shares had to pay tribute to the multi-week rally from EUR 21.36 at the end of September 2020 to EUR 31.00 at the end of December. The share price of the Hamburg-based biotech company, which appeared today at 1.30 p.m. at the highly regarded 39th Annual J.P. Morgan Healthcare Conference (see see Evotec page), slipped back to the 20-day line, which was reached on Thursday of last week with a low of 28.39 euros. This was followed by a stabilization in the range between EUR 28.39 and EUR 28.79 – so there is currently support for the biotech share. Strengthened by the EMA 20 at 28.56 euros.
Evotec’s share price is currently stable. Yesterday I went 29.31 euros from XETRA trading, the current indications for the TecDAX value are only a few cents lower. In terms of the chart, the stabilization in the area around the rising EMA 20 could continue. If, however, the price falls below EUR 28.39 / EUR 28.79, further support could take effect at EUR 27.77 / EUR 27.95 – albeit of a weaker type. Strong support for the Evotec share can be found in the broad zone below EUR 27.29 and thus not too far removed from the current price level.